RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: sickle cell disease
Accession: DOID:0081445
browse the term
Definition: A blood protein disease that is characterized by chronic hemolytic anemia and intermittent vaso-occlusive events that result in tissue ischemia leading to acute and chronic pain as well as organ damage that can affect any organ system, resulting from the replacement of one of the beta-globin subunits in hemoglobin with atypical hemoglobin molecules called hemoglobin S which can distort red blood cells into a sickle or crescent shape. Sickle cell disease subtypes should include a detailed genotypic description for the hemoglobin molecules (e.g., Hb S/S, Hb S/C, Hb S/β0-thalassemia). (DO)
Synonyms: xref: MIM:603903
GViewer not supported for the selected species.
G
Hmox1
heme oxygenase 1
ISO
associated with Anemia, Sickle Cell;DNA:repeat:promoter
RGD
PMID:22966170
RGD:10755560
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
G
Nos3
nitric oxide synthase 3
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:repeats:intron: associated with Anemia, Sickle Cell;DNA:polymorphism: :-786T>C(human)
RGD
PMID:14687036 PMID:25263931
RGD:11533931 RGD:11533934
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
G
Vegfa
vascular endothelial growth factor A
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:SNPs: : rs2010963, rs833068,rs3025020(human) associated with Anemia, Sickle Cell;DNA:polymorphism:583C > T (human)
RGD
PMID:22925497 PMID:25130874
RGD:11075233 RGD:11075235
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
G
Alad
aminolevulinate dehydratase
ISO
protein:increased activity:erythrocyte
RGD
PMID:900140
RGD:12904674
NCBI chrNW_004936559:226,481...237,258
Ensembl chrNW_004936559:226,424...241,684
G
Apob
apolipoprotein B
treatment
ISO
RGD
PMID:24035168
RGD:11354943
NCBI chrNW_004936493:10,509,118...10,549,144
Ensembl chrNW_004936493:10,509,118...10,549,144
G
Bcl11a
BCL11 transcription factor A
treatment severity
ISO
DNA:snp, haplotype:intron:c.386-24983T>C (rs4671393) (human)
RGD
PMID:18667698 PMID:21998251 PMID:22360576
RGD:11099970 RGD:11099996 RGD:11100007
NCBI chrNW_004936491:6,021,340...6,118,103
Ensembl chrNW_004936491:6,021,343...6,118,568
G
C3
complement C3
severity
ISO
protein:increased processing
RGD
PMID:3896597 PMID:7554454
RGD:11040773 RGD:11040777
NCBI chrNW_004936588:3,985,732...4,023,221
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chrNW_004936493:5,308,268...5,332,934
Ensembl chrNW_004936493:5,310,228...5,332,918
G
Cd36
CD36 molecule (CD36 blood group)
treatment
ISO
protein:increased expression:erythrocyte
RGD
PMID:18322255 PMID:20015873
RGD:11041114 RGD:6893506
NCBI chrNW_004936810:791,823...838,303
Ensembl chrNW_004936810:758,182...838,365
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:plasma (human)
RGD
PMID:24368019
RGD:11352270
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
G
Cfb
complement factor B
ISO
protein:decreased activity
RGD
PMID:10440069 PMID:12793071
RGD:11041159 RGD:11041160
NCBI chrNW_004936727:1,595,872...1,602,274
Ensembl chrNW_004936727:1,595,499...1,602,215
G
Dhodh
dihydroorotate dehydrogenase (quinone)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chrNW_004936475:21,863,627...21,877,660
Ensembl chrNW_004936475:21,862,166...21,877,711
G
F2
coagulation factor II, thrombin
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:8191393 PMID:26286849
RGD:11565074 RGD:11565080
NCBI chrNW_004936562:2,371,725...2,388,617
Ensembl chrNW_004936562:2,372,044...2,388,650
G
F3
coagulation factor III, tissue factor
ISO
protein:increased expression:plasma
RGD
PMID:15795541
RGD:11341683
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
G
Gch1
GTP cyclohydrolase 1
sexual_dimorphism
ISO
DNA:SNP, haplotype:rs8007267 (human)
RGD
PMID:24136375
RGD:329961567
NCBI chrNW_004936697:232,048...275,420
G
Gpx1
glutathione peroxidase 1
treatment
ISO
protein:decreased expression:penis
RGD
PMID:19951064 PMID:20846340 PMID:22620981
RGD:11352756 RGD:11352757 RGD:11352775
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
G
Gsr
glutathione-disulfide reductase
ISO
protein:increased activity:erythrocyte:
RGD
PMID:14717789
RGD:11059503
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
G
Hbe1
hemoglobin subunit epsilon 1
treatment
ISO
DNA:SNP: :rs7130110 (human)
RGD
PMID:12124399 PMID:23409025
RGD:11353858 RGD:11353860
NCBI chrNW_004937116:173,006...174,535
G
Hk1
hexokinase 1
ISO
protein:alternative form:erythrocyte
RGD
PMID:5686464
RGD:11353884
NCBI chrNW_004936521:9,067,062...9,139,112
Ensembl chrNW_004936521:9,066,999...9,159,793
G
Hmbs
hydroxymethylbilane synthase
ISO
protein:increased activity:erythrocyte
RGD
PMID:900140
RGD:12904674
NCBI chrNW_004936542:4,037,888...4,046,089
Ensembl chrNW_004936542:4,037,201...4,050,810
G
Hmox1
heme oxygenase 1
treatment
ISO
RGD
PMID:11238038 PMID:20306336
RGD:10755563 RGD:10755565
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:24281564
RGD:11046271
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
G
Il5
interleukin 5
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:25843670
RGD:11354938
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
G
LOC101976500
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16597321
NCBI chrNW_004936475:21,841,054...21,845,821
G
Mdm2
MDM2 proto-oncogene
ISO
RGD
PMID:21085184
RGD:10412315
NCBI chrNW_004936545:6,709,903...6,732,334
G
Mthfr
methylenetetrahydrofolate reductase
no_association severity
ISO
DNA:SNP: :677C>T (human) DNA:SNP: :1298A>C (human)
RGD
PMID:20113291 PMID:22924497
RGD:10449403 RGD:10449420
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29255069
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
G
Nos3
nitric oxide synthase 3
severity
ISO
DNA:polymorphisms,haplotype:intron,cds:894G>T, -786T>C(human)
RGD
PMID:24088668
RGD:11533647
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
G
Nppb
natriuretic peptide B
severity
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20408845 PMID:21689089
RGD:5685653
NCBI chrNW_004936474:683,325...684,662
Ensembl chrNW_004936474:683,325...684,665
G
Pecam1
platelet and endothelial cell adhesion molecule 1
severity
ISO
protein:increased expression:serum (human)
RGD
PMID:20306667
RGD:11541101
NCBI chrNW_004936541:4,873,459...4,919,787
Ensembl chrNW_004936541:4,873,182...4,937,500
G
Pgf
placental growth factor
ISO
protein:increased expression:plasma
RGD
PMID:20040765
RGD:6483588
NCBI chrNW_004936488:4,098,187...4,111,108
Ensembl chrNW_004936488:4,098,225...4,111,142
G
Pon1
paraoxonase 1
ISO
protein:decreased activity: serum (human)
RGD
PMID:24508012
RGD:11553835
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
G
Selp
selectin P
ISO
RGD
PMID:21071696
RGD:6219007
NCBI chrNW_004936481:17,076,660...17,112,501
Ensembl chrNW_004936481:17,076,536...17,107,963
G
Spta1
spectrin alpha, erythrocytic 1
ISO
OMIM:603903
MouseDO
NCBI chrNW_004936740:1,686,218...1,759,083
Ensembl chrNW_004936740:1,686,218...1,759,078
G
Tgfb1
transforming growth factor beta 1
ISO
protein:increased expression:plasma:
RGD
PMID:26928604
RGD:11062147
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8140855 PMID:14965870
RGD:10449460
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
G
Umps
uridine monophosphate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chrNW_004936725:553,278...564,846
Ensembl chrNW_004936725:549,804...565,141
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16916123
NCBI chrNW_004936748:785,491...802,791
Ensembl chrNW_004936748:785,455...803,048
G
Serpinf1
serpin family F member 1
ISO
protein:increased expression:retinal blood vessels (human)
RGD
PMID:12957143
RGD:8554869
NCBI chrNW_004936538:7,885,816...7,898,308
Ensembl chrNW_004936538:7,885,475...7,899,113
G
LOC101976500
haptoglobin
ISO
RGD
PMID:19023114 PMID:21595649
RGD:5147416 RGD:5147440
NCBI chrNW_004936475:21,841,054...21,845,821
G
Nos3
nitric oxide synthase 3
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:repeats:intron:
RGD
PMID:25263931
RGD:11533931
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
G
Pde9a
phosphodiesterase 9A
treatment
ISO
RGD
PMID:22833547
RGD:242905184
NCBI chrNW_004936500:1,201,843...1,266,818
Ensembl chrNW_004936500:1,203,437...1,267,095
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
ISO
RGD
PMID:23643401
RGD:11100023
NCBI chrNW_004936541:718,577...727,420
Ensembl chrNW_004936541:718,577...729,876
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all